Optimizing Early Sequencing And Treatment In Mm | Latest News RSS feed

Optimizing Early Sequencing And Treatment In Mm - Latest News

Color to Move Whole Genome Sequencing Into Clinical Care through 100,000-Person Initiative Focused on Polygenic Risk

SAN FRANCISCO, Jan. 7, 2019 /PRNewswire/ -- Today Color announced an initiative to help build the foundation for the first mainstream application of whole genome sequencing ... disease in order to ... read more

Quality and Polyfunctionality in Cell Therapy Development Can Broaden Therapeutic Options

Today, the results of this potentially paradigm-shifting approach to “cure” cancer have shown that it works, at least in some treatment ... sequencing data on some of these cell products were ... read more

NGS Tests Gain Further Coverage in the Market

Using precision medicine successfully means also using diagnostics and next-generation sequencing (NGS ... for assessment of minimal residual disease in patients with MM or ALL throughout treatment ... read more

Looking for another news?

A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)

Secondary/exploratory endpoints included clinical benefit (CBR ≥6-months) and objective response (ORR) rates, PFS, OS, safety, and whole-exome sequencing (WES ... of ENMD-2076 monotherapy in treatment ... read more

Piling on Drugs to Treat HER2-Positive Breast Cancer

They agreed that optimizing the sequence of chemotherapy, endocrine treatment and HER2-targeted drugs ... in patients with early-stage HER2- positive breast cancer who had completed Herceptin-based ... read more

Elekta Demonstrates Leadership in Precision Radiation Medicine at ESTRO 38

Monaco® HD treatment planning: the gold standard for delivering fast and accurate treatment plans. With Smart Sequencing and true multicriterial optimization, Monaco HD achieves superior plan quality ... read more

Blood test shows potential for early detection of lung cancer

The findings, from one of the first studies to explore whether sequencing ... for early-detection tests for lung cancer that can be easily implemented by health-care systems. These are promising early ... read more

OncoCyte Corporation (OCX) Q1 2019 Earnings Call Transcript

Late last year, we announced our successful transition to the Thermo Fisher Ion Torrent Gene Studio S5 next generation sequencing platform ... Detecting lung cancer early will allow for earlier ... read more

Chemical reprogramming enhances homology-directed genome editing in zebrafish embryos

By further optimizing the reaction environment and repair template ... which is ~9 times more effective than RS-1 alone. Furthermore, combined treatment with both NU7441 and RS-1 did not further ... read more

Celgene to Present New and Updated Data across a Range of Blood Diseases at EHA 2018

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that data from a broad range of early and late stage ... model of multiple myeloma (MM) patient outcomes based ... read more

How Regeneron Can Take Its Sad Song And Make It (Much) Better

The company initially omitted $400 MM expected to be paid to Alnylam (ALNY ... this is very analogous to our early experience with CD20xCD3 monotherapy... with our lowest doses, we actually ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us